17.11.2016 | Letter to the Editor
First-line all-oral NORCAP (vinorelbine/capecitabine) might be alternative to taxane-based chemotherapy for HER2-negative metastatic breast cancer
Erschienen in: Breast Cancer Research and Treatment | Ausgabe 2/2017
Einloggen, um Zugang zu erhalten